XML 27 R18.htm IDEA: XBRL DOCUMENT
v3.23.1

SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2022
Defined Benefit Plan Disclosure [Line Items] |
SCHEDULE OF PREVIOUSLY REPORTED CONSOLIDATED STATEMENTS OF OPERATIONS | SCHEDULE OF PREVIOUSLY REPORTED CONSOLIDATED STATEMENTS OF OPERATIONS
|  | Three Months Ended June 30, 2022 |
|  | As Reported |  |  | Adjustment |  |  | As Corrected |
Basic earnings (loss) per share |  |  | 8.40 |  |  |  | 1.42 |  |  |  | 9.82 |
Diluted earnings (loss) per share |  |  | (1.50 | ) |  |  | 10.11 |  |  |  | 8.61 |
Weighted average number of shares outstanding – Basic |  |  | 1,249,219 |  |  |  | (180,062 | ) |  |  | 1,069,157 |
Weighted average number of shares outstanding - Diluted |  |  | 1,399,286 |  |  |  | (180,062 | ) |  |  | 1,219,224 |
|  | Six Months Ended June 30, 2022 |
|  | As Reported |  |  | Adjustment |  |  | As Corrected |
Basic earnings (loss) per share |  |  | 11.25 |  |  |  | 1.34 |  |  |  | 12.59 |
Diluted earnings (loss) per share |  |  | (8.85 | ) |  |  | (3.99 | ) |  |  | (12.84 | )
Weighted average number of shares outstanding – Basic |  |  | 1,149,219 |  |  |  | (124,111 | ) |  |  | 1,025,108 |
Weighted average number of shares outstanding - Diluted |  |  | 1,342,315 |  |  |  | (274,080 | ) |  |  | 1,068,236 |
SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW | Cash and restricted cash reported on our Condensed Consolidated Balance Sheets are reconciled to the total shown on our Condensed Consolidated Statements of Cash Flows as follows: SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW
|  | June 30, 2022 |  |  | June 30, 2021 |
Cash |  | $ | 2,979,769 |  |  | $ | 6,348,415 |
Restricted cash |  |  | 1,417,635 |  |  |  | 484,350 |
Total cash and restricted cash |  | $ | 4,397,404 |  |  | $ | 6,832,765 |
SCHEDULE OF EARN OUT LIABILITY | SCHEDULE OF FAIR VALUE OF WARRANT COMMITMENT
|  | June 30, 2022 |  |  | December 31, 2021 |
Stock price |  | $ | 2.11 |  |  | $ | 6.44 |
Volatility |  |  | 105 | % |  |  | 90 | %
Time to expiry |  |  | 4.51 |  |  |  | 5 |
Dividend yield |  |  | 0 | % |  |  | 0 | %
Risk free rate |  |  | 3.00 | % |  |  | 1.10 | %
SCHEDULE OF RECONCILES WARRANT COMMITMENT | The following reconciles fair value of the liability classified warrants: SCHEDULE OF RECONCILES WARRANT COMMITMENT
|  |  | Series B Warrant Commitment |  |  |  | Series B warrant liabilities |  |  |  | Placement agent warrants |  |  | Total |
|  | Three and Six Months ended June 30, 2022 |
|  | Series B Warrant Commitment |  |  | Series B warrant liabilities |  |  | Placement agent warrants |  |  | Total |
Beginning balance |  | $ | 37,652,808 |  |  | $ | - |  |  | $ | - |  |  | $ | 37,652,808 |
Initial recognition |  |  | - |  |  |  | 55,061,119 |  |  |  | 1,525,923 |  |  |  | 56,587,042 |
Unrealized (gain) loss |  |  | 17,408,311 |  |  |  | (31,980,437 | ) |  |  | (946,461 | ) |  |  | (15,518,587 | )
Warrants exercised or transferred |  |  | (55,061,119 | ) |  |  |  |  |  |  |  |  |  |  | (55,061,119 | )
Ending balance, March 31, 2022 |  | $ | - |  |  | $ | 23,080,682 |  |  | $ | 579,462 |  |  | $ | 23,660,144 |
Unrealized gain |  |  | - |  |  |  | (12,322,737 | ) |  |  | (310,514 | ) |  |  | (12,633,251 | )
Ending balance, June 30, 2022 |  |  | - |  |  |  | 10,757,945 |  |  |  | 268,948 |  |  |  | 11,026,893 |
|  |  | Series B Warrant Commitment |  |  |  | Total |
|  | December 31, 2021 |
|  | Series B Warrant Commitment |  |  | Total |
Beginning balance |  | $ | - |  |  | $ | - |
Initial recognition |  |  | 20,244,497 |  |  |  | 20,244,497 |
Unrealized gain |  |  | 17,408,311 |  |  |  | 17,408,311 |
Ending balance |  | $ | 37,652,808 |  |  | $ | 37,652,808 |
SCHEDULE OF FAIR VALUE MEASUREMENTS | SCHEDULE OF FAIR VALUE MEASUREMENTS
|  | June 30, 2022 |  |  | December 31, 2021 |
Valuation technique |  |  | Discounted cash flow |  |  |  | Discounted cash flow |
Significant unobservable input |  |  | Projected revenue and probability of achievement |  |  |  | Projected revenue and probability of achievement |
SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE | SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE
|  | June 30, 2022 |  |  | December 31, 2021 |
Beginning balance – January 1 |  | $ | 3,813,878 |  |  | $ | 2,931,418 |
Acquisitions and Settlements |  |  |  |  |  |  |  |
JP Kush Acquisition |  |  | - |  |  |  | 1,694,166 |
Barra Acquisition |  |  | 600,000 |  |  |  | - |
CCS Write-off |  |  | - |  |  |  | (81,368 | )
Altruis partial settlement |  |  | (84,473 | ) |  |  | (452,236 | )
Montana final settlement |  |  | (326,935 | ) |  |  | - |
Period adjustments: |  |  |  |  |  |  |  |
Fair value changes and accretion included in earnings* |  |  | 354,963 |  |  |  | (278,102 | )
Ending balance |  | $ | 4,357,433 |  |  | $ | 3,813,878 |
Less: Current portion |  |  | (3,683,596 | ) |  |  | (3,297,855 | )
Ending balance, less current portion |  |  | 673,837 |  |  |  | 516,023 |
* | Recorded as a reduction to general and administrative expenses
SCHEDULE OF DISAGGREGATION REVENUE | The following table disaggregates the Company’s revenue by line of business, showing commissions earned: SCHEDULE OF DISAGGREGATION REVENUE
Three Months ended June 30, 2022 |  | Medical/Life |  |  | Property and Casualty |  |  | Total |
Regular |  |  |  |  |  |  |  |  |  |  |  |
EBS |  | $ | 184,851 |  |  | $ | - |  |  | $ | 184,851 |
USBA |  |  | 12,319 |  |  |  | - |  |  |  | 12,319 |
CCS/UIS |  |  | - |  |  |  | 57,195 |  |  |  | 57,195 |
Montana |  |  | 451,705 |  |  |  | - |  |  |  | 451,705 |
Fortman |  |  | 357,334 |  |  |  | 205,804 |  |  |  | 563,138 |
Altruis |  |  | 882,171 |  |  |  | - |  |  |  | 882,171 |
Kush |  |  | 425,449 |  |  |  | - |  |  |  | 425,449 |
Medigap |  |  | 1,359,976 |  |  |  | - |  |  |  | 1,359,976 |
Barra |  |  | 69,925 |  |  |  | 200,397 |  |  |  | 270,322 |
|  | $ | 3,743,730 |  |  | $ | 463,396 |  |  | $ | 4,207,126 |
Six Months ended June 30, 2022 |  | Medical/Life |  |  | Property and Casualty |  |  | Total |
Regular |  |  |  |  |  |  |  |  |  |  |  |
EBS |  | $ | 406,035 |  |  | $ | - |  |  | $ | 406,035 |
USBA |  |  | 25,906 |  |  |  | - |  |  |  | 25,906 |
CCS/UIS |  |  | - |  |  |  | 101,077 |  |  |  | 101,077 |
Montana |  |  | 958,426 |  |  |  | - |  |  |  | 958,426 |
Fortman |  |  | 689,933 |  |  |  | 403,064 |  |  |  | 1,092,997 |
Altruis |  |  | 2,187,043 |  |  |  | - |  |  |  | 2,187,043 |
Kush |  |  | 864,040 |  |  |  | - |  |  |  | 864,040 |
Medigap |  |  | 2,537,061 |  |  |  | - |  |  |  | 2,537,061 |
Barra |  |  | 69,925 |  |  |  | 200,397 |  |  |  | 270,322 |
|  | $ | 7,738,369 |  |  | $ | 704,538 |  |  | $ | 8,442,907 |
Three Months ended June 30, 2021 |  | Medical/Life |  |  | Property and Casualty |  |  | Total |
Regular |  |  |  |  |  |  |  |  |  |  |  |
EBS |  |  | 207,201 |  |  |  | - |  |  |  | 207,201 |
USBA |  |  | 15,395 |  |  |  | - |  |  |  | 15,395 |
CCS/UIS |  |  | - |  |  |  | 65,348 |  |  |  | 65,348 |
Montana |  |  | 404,740 |  |  |  | - |  |  |  | 404,740 |
Fortman |  |  | 276,634 |  |  |  | 226,337 |  |  |  | 502,971 |
Altruis |  |  | 729,874 |  |  |  | - |  |  |  | 729,874 |
Kush |  |  | 265,318 |  |  |  | - |  |  |  | 265,318 |
|  | $ | 1,899,162 |  |  | $ | 291,685 |  |  | $ | 2,190,847 |
Six Months ended June 30, 2021 |  | Medical/Life |  |  | Property and Casualty |  |  | Total |
Regular |  |  |  |  |  |  |  |  |  |  |  |
EBS |  | $ | 416,195 |  |  | $ | - |  |  | $ | 416,195 |
USBA |  |  | 27,620 |  |  |  | - |  |  |  | 27,620 |
CCS/UIS |  |  | - |  |  |  | 154,166 |  |  |  | 154,166 |
Montana |  |  | 939,856 |  |  |  | - |  |  |  | 939,856 |
Fortman |  |  | 526,435 |  |  |  | 434,109 |  |  |  | 960,544 |
Altruis |  |  | 1,750,878 |  |  |  | - |  |  |  | 1,750,878 |
Kush |  |  | 265,318 |  |  |  | - |  |  |  | 265,318 |
|  | $ | 3,926,302 |  |  | $ | 588,275 |  |  | $ | 4,514,577 |
SCHEDULE OF CONCENTRATIONS OF REVENUES | The following, are customers representing 10% or more of total revenue: SCHEDULE OF CONCENTRATIONS OF REVENUES
Insurance Carrier |  | 2022 |  |  | 2021 |
|  | For the three months ended June 30, |
Insurance Carrier |  | 2022 |  |  | 2021 |
LTC Global |  |  | 30 | % |  |  | - | %
Priority Health |  |  | 20 | % |  |  | 31 | %
BlueCross BlueShield |  |  | - | % |  |  | 28 | %
Insurance Carrier |  | 2022 |  |  | 2021 |
|  | For the six months ended June 30, |
Insurance Carrier |  | 2022 |  |  | 2021 |
BlueCross BlueShield |  |  | 10 | % |  |  | 25 | %
Priority Health |  |  | 25 | % |  |  | 33 | %
LTC Global |  |  | 28 | % |  |  | - | %
SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION | SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION
Account |  | 12/31/2020 As reported |  |  | Adjustment |  |  | 12/31/2020 Adjusted |
Earn-out liability |  |  | 2,631,418 |  |  |  | 300,000 |  |  |  | 2,931,418 |
Goodwill |  |  | 9,265,070 |  |  |  | (503,345 | ) |  |  | 8,761,725 |
Common stock issuable |  |  | 822,116 |  |  |  | (482,116 | ) |  |  | 340,000 |
Additional paid-in-capital |  |  | 11,377,123 |  |  |  | 182,116 |  |  |  | 11,559,239 |
Accumulated Deficit |  |  | (12,482,281 | ) |  |  | 122,601 |  |  |  | (12,359,680 | )
Account |  | 3/31/2021 As reported |  |  | Adjustment |  |  | 3/31/2021 Adjusted |
Common stock issuable |  |  | 482,116 |  |  |  | (482,116 | ) |  |  | 0 |
Additional paid-in-capital |  |  | 25,810,147 |  |  |  | 182,116 |  |  |  | 25,992,263 |
Accumulated Deficit |  |  | (13,123,609 | ) |  |  | 150,003 |  |  |  | (12,973,606 | )
Fair Value, Inputs, Level 3 [Member] |
Defined Benefit Plan Disclosure [Line Items] |
SCHEDULE OF EARN OUT LIABILITY | The Company values its Level 3 earn-out liability related to the Barra Acquisition using a Monte Carlo simulation in a risk-neutral framework (a special case of the Income Approach). The following summarizes the significant unobservable inputs: SCHEDULE OF EARN OUT LIABILITY
|  | June 30, 2022 |
WACC Risk Premium: |  |  | 14.6 | %
Volatility |  |  | 50 | %
Credit Spread: |  |  | 11 | %
Payment Delay (days) |  |  | 90 | %
Risk free rate |  |  | USD Yield Curve |
Discounting Convention: |  |  | Mid-period |
Number of Iterations |  |  | 100,000 |

X
- Definition Schedule of reconciles warrant commitment [Table Text Block] + References No definition available. + Details
Name: | RELI_ScheduleOfReconcilesWarrantCommitmentTableTextBlock
Namespace Prefix: | RELI_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Reported Consolidated Statements Of Operation [Table Text Block] + References No definition available. + Details
Name: | RELI_ScheduleOfReportedConsolidatedStatementsOfOperationTableTextBlock
Namespace Prefix: | RELI_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_DefinedBenefitPlanDisclosureLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 7 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794 + Details
Name: | us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(1)(a)) -URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(2)) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910 + Details
Name: | us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 16 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 21 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592 + Details
Name: | us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |